S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:IMGO

Imago BioSciences - IMGO Price Target & Analyst Ratings

$36.01
0.00 (0.00%)
(As of 01/11/2023)
Add
Compare
Today's Range
$36.01
$36.01
50-Day Range
$35.64
$36.01
52-Week Range
$11.56
$36.09
Volume
N/A
Average Volume
171,367 shs
Market Capitalization
$1.22 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.00

Imago BioSciences Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$36.00
-0.03% Downside
High Prediction$36.00
Average Prediction$36.00
Low Prediction$36.00
TypeCurrent
2/2/22 to 2/2/23
1 Month Ago
1/3/22 to 1/3/23
3 Months Ago
11/4/21 to 11/4/22
1 Year Ago
2/2/21 to 2/2/22
Consensus Rating
Hold
Hold
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$36.00$36.00$32.33$34.33
Predicted Upside-0.03% Downside1.08% Upside73.59% Upside56.11% Upside
Get Imago BioSciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IMGO and its competitors with MarketBeat's FREE daily newsletter.


IMGO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IMGO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Imago BioSciences Stock vs. The Competition

TypeImago BioSciencesMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.65
2.46
Consensus RatingHoldBuyHold
Predicted Upside-0.03% Downside1,299.13% Upside8.10% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/28/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$35.00 ➝ $36.00+0.95%
11/24/2022Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set Target$36.00+1.01%
11/22/2022HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kapoor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$35.00 ➝ $36.00+1.15%
11/22/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform$36.00+1.15%
11/21/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$35.00 ➝ $36.00+1.15%
11/21/2022Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Driscoll
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$36.00+0.98%
(Data available from 2/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












IMGO Price Target - Frequently Asked Questions

What is Imago BioSciences's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Imago BioSciences stock is Hold based on the current 6 hold ratings for IMGO. The average twelve-month price prediction for Imago BioSciences is $36.00 with a high price target of $36.00 and a low price target of $36.00. Learn more on IMGO's analyst rating history.

Do Wall Street analysts like Imago BioSciences more than its competitors?

Analysts like Imago BioSciences less than other Medical companies. The consensus rating for Imago BioSciences is Hold while the average consensus rating for medical companies is Buy. Learn more on how IMGO compares to other companies.

Is Imago BioSciences being downgraded by Wall Street analysts?

Over the previous 90 days, Imago BioSciences's stock had 6 downgrades by analysts.

Does Imago BioSciences's stock price have much upside?

According to analysts, Imago BioSciences's stock has a predicted upside of 1.08% based on their 12-month price targets.

What analysts cover Imago BioSciences?

Imago BioSciences has been rated by Cowen, Cowen, Guggenheim, HC Wainwright, Jefferies Financial Group, Stifel Nicolaus, and Wedbush in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:IMGO) was last updated on 2/2/2023 by MarketBeat.com Staff